Sangamo Therapeutics (SGMOQ) EPS (Diluted) Growth (1y) (2021 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) EPS (Diluted) Growth (1y) (2021 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | 38.64% |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 68.53% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 162.14% |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | -102.51% |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 505.52% |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -15.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -15.13% |
| Sep 30, 2025 | -362.14% |
| Jun 30, 2025 | 56.10% |
| Mar 31, 2025 | 48.98% |
| Dec 31, 2024 | 66.44% |
| Sep 30, 2024 | 107.45% |
| Jun 30, 2024 | 73.03% |
| Mar 31, 2024 | -317.91% |
| Dec 31, 2023 | -2.70% |
| Sep 30, 2023 | -74.80% |
| Jun 30, 2023 | -125.41% |
| Mar 31, 2023 | 141.49% |
| Dec 31, 2022 | -29.85% |
| Sep 30, 2022 | -2.55% |
| Jun 30, 2022 | 11.05% |
| Mar 31, 2022 | 6.21% |
| Dec 31, 2021 | 14.33% |
| Sep 30, 2021 | -2,968.83% |
| Jun 30, 2021 | -26.59% |
| Mar 31, 2021 | 16.25% |